Detalhe da pesquisa
1.
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
Stroke
; 37(1): 139-44, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16306456
2.
Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients.
Thromb Haemost
; 90(6): 1100-5, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14652643
3.
Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Thromb Haemost
; 90(2): 252-9, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12888872
4.
Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Haematologica
; 88(10): 1157-62, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14555312